Status:
COMPLETED
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Memory Impairment
Eligibility:
All Genders
21-45 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as asse...
Eligibility Criteria
Inclusion
- Right handed
- 12th grade education or equivalent
- Able to read and write English as primary language
Exclusion
- History of head injury
- Substance abuse or dependence
- History of claustrophobia
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00985933
Start Date
February 1 2010
End Date
April 1 2011
Last Update
May 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
New Haven, Connecticut, United States